純利益 & Net Margin
IRRA PT. Itama Ranoraya Tbk
597.097,00
396
-2 (-0,50%)
2020
60.521 (10.73%)
2021
112.155 (8.5%)
2022
48.004 (6.37%)
2023
5.198 (0.75%)
2024
n/a
PEVE PT. Penta Valent Tbk
529.686,00
300
+4 (+1,00%)
2020
269 (0.02%)
2021
19.276 (1.08%)
2022
23.546 (1.1%)
2023
36.171 (1.46%)
2024
n/a
OBAT PT. Brigit Biofarmaka Teknologi Tbk
504.000,00
840
+135 (+19,00%)
2020
n/a
2021
15.649 (41.34%)
2022
12.384 (32.17%)
2023
11.973 (21.03%)
2024
n/a
LABS PT. UBC Medical Indonesia Tbk
438.450,00
111
-2 (-2,00%)
 
MMIX PT. Multi Medika Internasional Tbk
415.236,00
173
+1 (+1,00%)
2020
352 (23.75%)
2021
10.331 (25.52%)
2022
23.668 (13.52%)
2023
16.512 (9.43%)
2024
n/a
IKPM PT. Ikapharmindo Putramas Tbk
404.318,00
240
-2 (-0,83%)
2020
n/a
2021
n/a
2022
16.577 (4.16%)
2023
15.337 (3.48%)
2024
n/a
SURI PT. Maja Agung Latexindo Tbk
316.718,00
50
0 (0%)
2020
n/a
2021
n/a
2022
10.226 (10.96%)
2023
5.468 (6.69%)
2024
n/a
HALO PT. Haloni Jane Tbk
282.501,00
50
0 (0%)
2020
n/a
2021
n/a
2022
n/a
2023
16.996 (7.35%)
2024
n/a
PEHA PT. Phapros Tbk
255.360,00
304
-12 (-4,00%)
2020
7.154 (0.73%)
2021
11.070 (1.05%)
2022
28.069 (2.4%)
2023
5.959 (0.59%)
2024
n/a
DGNS PT. Diagnos Laboratorium Utama Tbk
227.500,00
180
-1 (-0,55%)
2020
52.686 (28.76%)
2021
64.303 (21.28%)
2022
12.664 (6.57%)
2023
-13.655 (-9.37%)
2024
n/a
PRIM PT. Royal Prima Tbk
199.321,00
59
-1 (-1,67%)
2020
38.169 (14.65%)
2021
75.433 (12.57%)
2022
21.589 (8.24%)
2023
-2.746 (-1.03%)
2024
n/a
MEDS PT. Hetzer Medical Indonesia Tbk
78.125,00
50
0 (0%)
2020
n/a
2021
n/a
2022
237 (0.63%)
2023
-3.570 (-15.71%)
2024
n/a
INAF PT. Indofarma Tbk
0
0
0 (0%)
2020
27 (0%)
2021
-37.580 (-1.29%)
2022
-428.462 (-37.45%)
2023
-720.993 (-137.7%)
2024
n/a
RSGK PT. Kedoya Adyaraya Tbk
0
0
0 (0%)
2020
n/a
2021
52.781 (12.13%)
2022
26.179 (7.29%)
2023
25.188 (6.75%)
2024
n/a
SCPI PT. Organon Pharma Indonesia Tbk
0
0
0 (0%)
2020
218.362 (7.55%)
2021
118.691 (5.5%)
2022
174.782 (7.47%)
2023
187.701 (6.83%)
2024
n/a